Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Apr 27,2016
Genetic Approach May Lead to New Treatments for Digestive Diseases
    Scientists at the University of Massachusetts Medical School (UMMS) say they have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system. This finding, based on studying calcium ion-controlled pathways in mice, may lead to new treatments for a host of digestive disorders,Read more
More
Genetic Approach May Lead to New Treatments for Digestive Diseases
Apr 27,2016
Medicilon in Situ Hybridization Technology Service
Definition: in situ hybridization (insituhybridization) is a kind of molecular hybridization, which is a kind of hybridization of the labeled probe directly to the nucleic acid to be tested in the tissue or cell, and the principle of immunocytochemistry uses a suitable detection system to target A method for precise and quantitative positioning of nucleicRead more
More
Medicilon in Situ Hybridization Technology Service
Apr 27,2016
Fluorescence in Situ Hybridization
Fluorescence in situ hybridization can be used to detect specific DNA or RNA in cells to determine the expression and location of specific genes. It can also be used to detect chromosomal changes in tumors or other diseases. Fluorescence in situ hybridization FISH (fluorescence in situ hybridization) technology is a new positioning technology developed inRead more
More
Fluorescence in Situ Hybridization
Apr 26,2016
Kidney Function Protein Exhibits Role in Nervous System
    Scientists at the University of Louisville have discovered that a protein previously known for its role in kidney function also plays a significant role in the nervous system. In an article ("The Adaptor Protein CD2AP Is a Coordinator of Neurotrophin Signaling-Mediated Axon Arbor Plasticity”) in the April issue of the Journal of Neuroscience, they show that the adaptorRead more
More
Kidney Function Protein Exhibits Role in Nervous System
Apr 26,2016
Findings Point to a Novel Approach to the Treatment of Diabetes
    Blocking the hormone that raises sugar levels in the blood could increase insulin levels while keeping blood sugar levels down. A new study in mice (“Blockade of Glucagon Signaling Prevents or Reverses Diabetes Onset Only If Residual ß-Cells Persist”), to be published in eLife, points to a novel way to treat diabetes, but only in someRead more
More
Apr 25,2016
Novel Epigenetic Drug Therapeutics Revealed
    As the 2016 American Association for Cancer Research meeting begins to downshift toward a close, the presentation sessions certainly did not suffer from a lack of enthusiasm from attendees or high-quality research from presenters. Of particular note was a major symposium that discussed next-generation epigenetic therapeutics.       In the past several years, there have beenRead more
More
Novel Epigenetic Drug Therapeutics Revealed
Apr 25,2016
Laser Driven Protein Transport Reveals Epigenetic Dynamics
    A new technique for probing the functions of genes and proteins works by enabling the laser-directed movement of proteins from one cellular location to another. The technique, a form of optogenetics, has already been used to export an epigenetically active protein from the nucleus. Soon after this relocation was accomplished, a rapid fading of particularRead more
More
Laser Driven Protein Transport Reveals Epigenetic Dynamics
Apr 21,2016
CRISPR as a Screening Tool for Drug Targets
Once again the quality of research presented at the annual American Association for Cancer Research (AACR) meeting transcends excellence. Researchers from around the globe have descended on the city of New Orleans to exchange ideas that they all hope will lead them down the path toward the next impactful cancer therapeutic. There is certainly noRead more
More
CRISPR as a Screening Tool for Drug Targets
Apr 21,2016
Computer Algorithm Helps Characterize Cancerous Genomic Variations
Scientists at the University of California San Diego School of Medicine and the Broad Institute say they have developed a new computer algorithm—REVEALER—to better characterize the functional context of genomic variations in cancer. The tool, described in a paper ("Characterizing Genomic Alterations in Cancer by Complementary Functional Associations”) published in Nature Biotechnology, is designed toRead more
More
Computer Algorithm Helps Characterize Cancerous Genomic Variations
Apr 20,2016
Improvement of Gene Editing for Immunotherapy
    The gene-editing tool TALEN can be used to inactivate PD-1-mediated immunosuppression and enhance the efficacy of a type of immunotherapy called adoptive T-cell transfer against solid tumors, according to a preclinical study published in Cancer Research, a journal of the American Association for Cancer Research.  Some of the most impressive results were provided by aRead more
More
Improvement of Gene Editing for Immunotherapy
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->